![Adjuvant Treatment for Older Women with Invasive Breast Cancer - Trevor A Jolly, Grant R Williams, Sita Bushan, Mackenzi Pergolotti, Kirsten A Nyrop, Ellen L Jones, Hyman B Muss, 2016 Adjuvant Treatment for Older Women with Invasive Breast Cancer - Trevor A Jolly, Grant R Williams, Sita Bushan, Mackenzi Pergolotti, Kirsten A Nyrop, Ellen L Jones, Hyman B Muss, 2016](https://journals.sagepub.com/cms/10.2217/whe.15.92/asset/images/large/10.2217_whe.15.92-fig2.jpeg)
Adjuvant Treatment for Older Women with Invasive Breast Cancer - Trevor A Jolly, Grant R Williams, Sita Bushan, Mackenzi Pergolotti, Kirsten A Nyrop, Ellen L Jones, Hyman B Muss, 2016
![Magee Equations™ and response to neoadjuvant chemotherapy in ER+/HER2-negative breast cancer: a multi-institutional study - Modern Pathology Magee Equations™ and response to neoadjuvant chemotherapy in ER+/HER2-negative breast cancer: a multi-institutional study - Modern Pathology](https://mp.uscap.org/cms/asset/9ae860b0-dcac-4b6d-9b51-565655ad9366/gr1.jpg)
Magee Equations™ and response to neoadjuvant chemotherapy in ER+/HER2-negative breast cancer: a multi-institutional study - Modern Pathology
![Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update | Journal of Clinical Oncology Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2022/jco.2022.40.issue-16/jco.22.00069/20230316/images/abs-fig.jpg)
Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update | Journal of Clinical Oncology
![A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints - The Lancet Oncology A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints - The Lancet Oncology](https://www.thelancet.com/cms/attachment/fe468876-c413-4818-b918-0f871d688eda/gr1_lrg.jpg)
A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints - The Lancet Oncology
![Validity of Adjuvant! Online program in older patients with breast cancer: a population-based study - The Lancet Oncology Validity of Adjuvant! Online program in older patients with breast cancer: a population-based study - The Lancet Oncology](https://www.thelancet.com/cms/attachment/d9703228-fc3a-4361-8574-cece79e56c05/gr1.jpg)
Validity of Adjuvant! Online program in older patients with breast cancer: a population-based study - The Lancet Oncology
![Prediction of quality of life in early breast cancer upon completion of adjuvant chemotherapy | npj Breast Cancer Prediction of quality of life in early breast cancer upon completion of adjuvant chemotherapy | npj Breast Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41523-021-00296-8/MediaObjects/41523_2021_296_Fig1_HTML.png)
Prediction of quality of life in early breast cancer upon completion of adjuvant chemotherapy | npj Breast Cancer
![JPM | Free Full-Text | Clinical Utility of Gene Expression Profiling Data for Clinical Decision-Making Regarding Adjuvant Therapy in Early Stage, Node-Negative Breast Cancer: A Case Report JPM | Free Full-Text | Clinical Utility of Gene Expression Profiling Data for Clinical Decision-Making Regarding Adjuvant Therapy in Early Stage, Node-Negative Breast Cancer: A Case Report](https://www.mdpi.com/jpm/jpm-02-00071/article_deploy/html/images/jpm-02-00071-g001.png)
JPM | Free Full-Text | Clinical Utility of Gene Expression Profiling Data for Clinical Decision-Making Regarding Adjuvant Therapy in Early Stage, Node-Negative Breast Cancer: A Case Report
![A multi‐institutional prediction model to estimate the risk of recurrence and mortality after mastectomy for T1‐2N1 breast cancer - Sittenfeld - 2022 - Cancer - Wiley Online Library A multi‐institutional prediction model to estimate the risk of recurrence and mortality after mastectomy for T1‐2N1 breast cancer - Sittenfeld - 2022 - Cancer - Wiley Online Library](https://acsjournals.onlinelibrary.wiley.com/cms/asset/b6de2dce-2a94-4150-ad30-2cf5c42d8be2/cncr34352-fig-0002-m.jpg)
A multi‐institutional prediction model to estimate the risk of recurrence and mortality after mastectomy for T1‐2N1 breast cancer - Sittenfeld - 2022 - Cancer - Wiley Online Library
![Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial | npj Breast Cancer Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial | npj Breast Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41523-021-00288-8/MediaObjects/41523_2021_288_Fig1_HTML.png)
Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial | npj Breast Cancer
![Cancers | Free Full-Text | A Comparison between the Online Prognostic Tool PREDICT and myBeST for Women with Breast Cancer in Malaysia Cancers | Free Full-Text | A Comparison between the Online Prognostic Tool PREDICT and myBeST for Women with Breast Cancer in Malaysia](https://www.mdpi.com/cancers/cancers-15-02064/article_deploy/html/images/cancers-15-02064-g001.png)
Cancers | Free Full-Text | A Comparison between the Online Prognostic Tool PREDICT and myBeST for Women with Breast Cancer in Malaysia
![Adjuvant! Online is overoptimistic in predicting survival of Asian breast cancer patients - ScienceDirect Adjuvant! Online is overoptimistic in predicting survival of Asian breast cancer patients - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0959804912000986-gr2.jpg)